In March 2025, The Lancet Respiratory Medicine published a phase 2 clinical study article on China's first DPP-1 inhibitor, HSK31858, led by Academician Nan-shan Zhong and Professor Wei-jie Guan from ...
When Channel 4 begins its new look free to air coverage of all UK horse racing from 1 January, it will do so as the first user of the Digital Production Partnership’s (DPP) Technical Standard for live ...
Merck Presents First Phase 3 Data in Japanese Patients for Omarigliptin, an Investigational Once-Weekly DPP-4 Inhibitor for Type 2 Diabetes.
Bronchiectasis is one of the most common highly heterogeneous chronic inflammatory airway diseases in China. It has a long course, heavy symptom burden, and is prone to recurrent acute exacerbations, ...
Merck & Co.’s drug indicated as a monotherapy and as an add-on to either metformin or TZDs. Merck & Co.’s Januvia™ (sitagliptin phosphate), which the company says is the first and only DPP-4 inhibitor ...
Dassault Systèmes said on the 27th that it officially won a project, the first in Korea, to link LCA (life cycle assessment) and DPP (digital product passport) with Cofinity X in collaboration with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results